BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 38453756)

  • 1. Exploring the interplay between triple-negative breast cancer stem cells and tumor microenvironment for effective therapeutic strategies.
    Zou Z; Luo T; Wang X; Wang B; Li Q
    J Cell Physiol; 2024 May; ():. PubMed ID: 38807378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies.
    Ali K; Nabeel M; Mohsin F; Iqtedar M; Islam M; Rasool MF; Hashmi FK; Hussain SA; Saeed H
    Med Oncol; 2024 Apr; 41(5):112. PubMed ID: 38592510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticle-Mediated Immunotherapy in Triple-Negative Breast Cancer.
    Wang R; Huang X; Chen X; Zhang Y
    ACS Biomater Sci Eng; 2024 May; ():. PubMed ID: 38815129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current advances in biomarkers for targeted therapy in triple-negative breast cancer.
    Fleisher B; Clarke C; Ait-Oudhia S
    Breast Cancer (Dove Med Press); 2016; 8():183-197. PubMed ID: 27785100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting triple negative breast cancer stem cells using nanocarriers.
    Dasari N; Guntuku GS; Pindiprolu SKSS
    Discov Nano; 2024 Mar; 19(1):41. PubMed ID: 38453756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast Cancer Stem-Like Cells in Drug Resistance: A Review of Mechanisms and Novel Therapeutic Strategies to Overcome Drug Resistance.
    Saha T; Lukong KE
    Front Oncol; 2022; 12():856974. PubMed ID: 35392236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future Therapies.
    Gupta GK; Collier AL; Lee D; Hoefer RA; Zheleva V; Siewertsz van Reesema LL; Tang-Tan AM; Guye ML; Chang DZ; Winston JS; Samli B; Jansen RJ; Petricoin EF; Goetz MP; Bear HD; Tang AH
    Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32846967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harnessing the synergistic potential of NK1R antagonists and selective COX-2 inhibitors for simultaneous targeting of TNBC cells and cancer stem cells.
    Singh MT; Thaggikuppe Krishnamurthy P; Magham SV
    J Drug Target; 2024 Dec; 32(3):258-269. PubMed ID: 38252517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer.
    Jain V; Kumar H; Anod HV; Chand P; Gupta NV; Dey S; Kesharwani SS
    J Control Release; 2020 Oct; 326():628-647. PubMed ID: 32653502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular Vesicles in Triple-Negative Breast Cancer: Immune Regulation, Biomarkers, and Immunotherapeutic Potential.
    Das K; Paul S; Ghosh A; Gupta S; Mukherjee T; Shankar P; Sharma A; Keshava S; Chauhan SC; Kashyap VK; Parashar D
    Cancers (Basel); 2023 Oct; 15(19):. PubMed ID: 37835573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Subtypes of Breast Cancer: A Review for Breast Radiologists.
    Johnson KS; Conant EF; Soo MS
    J Breast Imaging; 2021 Jan; 3(1):12-24. PubMed ID: 38424845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breaking barriers in triple negative breast cancer (TNBC) - Unleashing the power of antibody-drug conjugates (ADCs).
    Dri A; Arpino G; Bianchini G; Curigliano G; Danesi R; De Laurentiis M; Del Mastro L; Fabi A; Generali D; Gennari A; Guarneri V; Santini D; Simoncini E; Zamagni C; Puglisi F
    Cancer Treat Rev; 2024 Feb; 123():102672. PubMed ID: 38118302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting autophagy and beyond: Deconvoluting the complexity of Beclin-1 from biological function to cancer therapy.
    Ye J; Zhang J; Zhu Y; Wang L; Jiang X; Liu B; He G
    Acta Pharm Sin B; 2023 Dec; 13(12):4688-4714. PubMed ID: 38045051
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.